NTV Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
17,571
+1,338
+8% +$128K 0.17% 123
2025
Q4
$1.56M Sell
16,233
-495
-3% -$48.1K 0.17% 119
2025
Q3
$1.59M Sell
16,728
-402
-2% -$37K 0.17% 116
2025
Q2
$1.49M Sell
17,130
-300
-2% -$25.4K 0.18% 111
2025
Q1
$1.57M Sell
17,430
-652
-4% -$58.3K 0.21% 95
2024
Q4
$1.44M Sell
18,082
-208
-1% -$18K 0.19% 102
2024
Q3
$1.65M Buy
18,290
+2,924
+19% +$246K 0.22% 92
2024
Q2
$1.21M Sell
15,366
-286
-2% -$23.4K 0.17% 105
2024
Q1
$1.36M Buy
15,652
+207
+1% +$17.7K 0.21% 93
2023
Q4
$1.27M Sell
15,445
-1,645
-10% -$125K 0.21% 93
2023
Q3
$1.34M Buy
17,090
+444
+3% +$37.2K 0.24% 87
2023
Q2
$1.47M Buy
16,646
+172
+1% +$14.8K 0.26% 88
2023
Q1
$1.33M Sell
16,474
-2,245
-12% -$183K 0.25% 91
2022
Q4
$1.45M Sell
18,719
-1,710
-8% -$139K 0.29% 86
2022
Q3
$1.65M Sell
20,429
-1,010
-5% -$90.8K 0.35% 77
2022
Q2
$1.92M Sell
21,439
-458
-2% -$46.4K 0.38% 71
2022
Q1
$2.43M Sell
21,897
-850
-4% -$89.8K 0.41% 68
2021
Q4
$2.35M Buy
22,747
+3
+0% +$347 0.39% 70
2021
Q3
$2.85M Sell
22,744
-147
-0.6% -$19K 0.5% 56
2021
Q2
$2.84M Sell
22,891
-97
-0.4% -$12.2K 0.5% 58
2021
Q1
$2.72M Sell
22,988
-97
-0.4% -$11.4K 0.5% 60
2020
Q4
$2.7M Sell
23,085
-197
-0.8% -$21.7K 0.54% 57
2020
Q3
$2.42M Buy
23,282
+4
+0% +$402 0.57% 50
2020
Q2
$2.13M Buy
23,278
+553
+2% +$53K 0.55% 53
2020
Q1
$2.05M Buy
22,725
+286
+1% +$30.4K 0.67% 47
2019
Q4
$2.55M Sell
22,439
-97
-0.4% -$10.6K 0.65% 49
2019
Q3
$2.45M Buy
22,536
+128
+0.6% +$13.4K 0.7% 47
2019
Q2
$2.18M Buy
22,408
+3
+0% +$274 0.63% 49
2019
Q1
$2.04M Sell
22,405
-997
-4% -$89.2K 0.58% 52
2018
Q4
$2.13M Sell
23,402
-297
-1% -$27.8K 0.69% 46
2018
Q3
$2.33M Buy
23,699
+12,704
+116% +$1.17M 0.63% 52
2018
Q2
$941K Sell
10,995
-97
-0.9% -$8.1K 0.27% 99
2018
Q1
$890K Sell
11,092
-347
-3% -$28.6K 0.25% 102
2017
Q4
$924K Buy
11,439
+3
+0% +$240 0.26% 98
2017
Q3
$889K Sell
11,436
-1,446
-11% -$120K 0.26% 99
2017
Q2
$1.14M Sell
12,882
-1,724
-12% -$145K 0.35% 82
2017
Q1
$1.18M Sell
14,606
-397
-3% -$31K 0.37% 80
2016
Q4
$1.07M Buy
15,003
+203
+1% +$15.9K 0.37% 80
2016
Q3
$1.28M Buy
14,800
+2
+0% +$174 0.46% 68
2016
Q2
$1.28M Buy
14,798
+103
+0.7% +$8.33K 0.49% 64
2016
Q1
$1.1M Buy
14,695
+3
+0% +$226 0.42% 72
2015
Q4
$1.13M Sell
14,692
-1,498
-9% -$113K 0.45% 68
2015
Q3
$1.08M Buy
16,190
+12,638
+356% +$931K 0.35% 83
2015
Q2
$263K Sell
3,552
-533
-13% -$40.7K 0.08% 185
2015
Q1
$318K Buy
4,085
+102
+3% +$7.73K 0.09% 170
2014
Q4
$287K Buy
3,983
+3
+0.1% +$208 0.09% 173
2014
Q3
$246K Buy
3,980
+130
+3% +$8.27K 0.07% 179
2014
Q2
$245K Buy
3,850
+3
+0.1% +$182 0.07% 180
2014
Q1
$236K Sell
3,847
-48
-1% -$2.8K 0.08% 181
2013
Q4
$223K Buy
+3,895
New +$221K 0.08% 186

Other funds holding MDT

NTV Asset Management's MDT Position: Q1 2026 in Review

NTV Asset Management increased its Medtronic (MDT) stake by 8.2% in Q1 2026, buying an estimated $128K and bringing the position to 17,571 shares worth $1.52M. The position accounts for 0.17% of the portfolio, ranked #123.

NTV Asset Management first reported a position in MDT in Q4 2013 and has held it in 50 quarters since. The position peaked at $2.85M in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • NTV Asset Management held 17,571 shares of Medtronic worth $1.52M as of Q1 2026.
  • NTV Asset Management bought 1,338 Medtronic shares in Q1 2026, an estimated $128K.
  • Medtronic made up 0.17% of NTV Asset Management's portfolio in Q1 2026, its #123 holding.
  • NTV Asset Management first reported a position in Medtronic in Q4 2013 and has held it in 50 quarters since.
  • NTV Asset Management's Medtronic position peaked at $2.85M in Q3 2021.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.